Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Shares Issued (2021 - 2024)

Pharma-Bio Serv (PBSV) has disclosed Shares Issued for 5 consecutive years, with $1.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Shares Issued changed N/A year-over-year to $1.0, compared with a TTM value of $6.0 through Apr 2024, down 25.0%, and an annual FY2023 reading of $5.0, up 66.67% over the prior year.
  • Shares Issued was $1.0 for Q1 2024 at Pharma-Bio Serv, down from $5.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $5.0 in Q2 2023 and bottomed at $1.0 in Q1 2024.
  • Average Shares Issued over 4 years is $2.75, with a median of $2.5 recorded in 2021.
  • Peak annual rise in Shares Issued hit 50.0% in 2022, while the deepest fall reached 50.0% in 2022.
  • Year by year, Shares Issued stood at $2.0 in 2021, then soared by 50.0% to $3.0 in 2022, then surged by 66.67% to $5.0 in 2023, then crashed by 80.0% to $1.0 in 2024.
  • Business Quant data shows Shares Issued for PBSV at $1.0 in Q1 2024, $5.0 in Q2 2023, and $3.0 in Q1 2022.